Categories
Tags
Inflammatory Bowel Diseases
DateMay 8, 2023Reactive oxygen species (ROS) are by-products of normal cellular metabolism with low to moderate amounts being beneficial in several physiological processes in the intestine. Chemotherapy and radiotherapies are largely based upon ROS generation to destroy malignant cells by inducing apoptosis…Moderators
Boston Children's Hospital
Univ of Illinois at Chicago
DateMay 9, 2023Visceral pain is a leading cause of disability worldwide, affecting 20% of the population. Increased sensitivity to normal innocuous stimuli in the intestine is a hallmark of many organic and functional gastrointestinal disorders…Moderators
APHP
McMaster University
DateMay 7, 2023The Cochrane Gut group supports the production of high quality and methodologically rigorous reviews for a portfolio that includes upper GI, IBD and functional bowel disease topics in adults and children…Moderators
McMaster University
University of Central Lancashire, UK
DateMay 8, 2023This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format…Moderators
University of Virginia Health System
Massachusetts General Hospital
DateMay 8, 2023This session will provide attendees with an overview of physician advocacy, how it impacts the GI community and how to get involved…Moderators
University of Washington
Duke University School of Medicine
DateMay 9, 2023This session brings Chinese speaking experts together to provide a broad overview highlighting the best of AGA programming at Digestive Disease Week® (DDW) 2023 for Chinese speaking audiences…Moderator
University of Michigan
DateMay 7, 2023There are multiple new biologic agents that have been approved for the management of IBD over the past few years. In addition, high quality randomized controlled trials have examined optimization of these treatments through therapeutic drug monitoring…Moderators
Icahn School of Medicine, Mount Sinai
Northwestern Feinberg School of Medicine
DateMay 7, 2023In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…Moderators
Cleveland Clinic
ucsf
DateMay 8, 2023Management of diseases of the ileo-anal pouch and perianal Crohn’s disease is challenging and involves multidisciplinary medical and surgical care. This session review the contemporary management of these complex clinical situations…Moderators
Swedish Medical Center
Mayo Clinic, Rochester
DateMay 6, 2023State of the art - omic methods now provide deeper insight into the biologic architecture of IBD. This session will review state of the art advances in metabolomics, transcriptomics, and epigenetics in defining the biologic basis of IBD…Moderators
University of California, San Francisco
Brigham and Women's Hospital
DateMay 6, 2023The burden of IBD is rising globally. This session aims to understand the role of genetics in the development of IBD in diverse populations and define the pre-disease state in IBD. It will also explore the emerging field of multi-omics to clinically characterize IBD…Moderators
University of Otago, Christchurch
Icahn School of Medicine at Mount Sinai
DateMay 8, 2023Microbiome science in the gut has focused on the study of colonic, and more frequently, fecal communities. While the upper gastrointestinal tract has significantly lower bacterial density than the colon, it still harbors a dynamic microbial community…Moderators
University of California Los Angeles
Midwestern University
DateMay 6, 2023The role of nutrition and the microbiome is evident in IBD and functional bowel disorders. The microbiome can affect the way nutrients are metabolized in bioactive components. It is of important to understand the molecular sensors of such metabolized components…Moderators
McMaster University
DateMay 6, 2023This session highlights thecurrent FDA approved microbiome therapeutics and their applications and the exciting avenues being pursued for the next generation of microbiome therapeutics using gene editing and synthetic microbial communities…Moderators
Cedars-Sinai Medical Center
Penn Medicine
DateMay 6, 2023Through the history of gut microbiome research, basic, translational, and clinical studies revealed many critical roles played by gut-resident bacteria in affecting human health and disease…Moderators
McMaster University
University of California San Diego
DateMay 7, 2023SOCIETY: AGAModerators
Brigham and Women's Hospital
University of Massachusetts Medical School
DateMay 8, 2023SOCIETY: AGAModerators
ucsf
Massachusetts General Hospital
DateMay 7, 2023SOCIETY: DDWModerators
University of Chicago Division of the Biological Sciences
Mayo Clinic Rochester
DateMay 7, 2023SOCIETY: AGAModerators
Johns Hopkins
Weill Cornell Medicine
DateMay 7, 2023SOCIETY: AGAModerators
Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven
Cedars-Sinai Medical Center
DateMay 8, 2023SOCIETY: AGAModerators
Örebro University
University of Michigan
DateMay 8, 2023SOCIETY: AGAModerators
Cleveland Clinic Foundation
Case Western Reserve University School of Medicine
DateMay 8, 2023SOCIETY: AGAModerators
Yale School of Medicine
University Hospitals Leuven
DateMay 9, 2023SOCIETY: AGAModerators
University of North Carolina
University of North Carolina System
